Identification of histologically distinct conventional adenomas that arise predominately in patients with sessile serrated adenomas

American Journal of Surgical Pathology

Volumn 34, Issue 3, 2010, Pages 355-363

  Pai, Rish K ^a   MacKinnon, Alexander Craig ^b   Joseph, Loren ^b   Noffsinger, Amy ^b   Hart, John ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

CIMP; Colorectal cancer; Conventional adenoma; CpG island methylation; Hyperplastic polyp; Hyperplastic polyposis syndrome; Microsatellite instability; Sessile serrated adenoma; Sessile serrated polyp; Traditional serrated adenoma; Tubular adenoma

Indexed keywords

B RAF KINASE; BRAF PROTEIN, HUMAN; KRAS PROTEIN, HUMAN; MUC6 PROTEIN, HUMAN; MUCIN 6; ONCOPROTEIN; RAS PROTEIN;

ADENOMA; AGED; ARTICLE; CASE CONTROL STUDY; CHEMISTRY; CLASSIFICATION; COLON POLYP; COLON TUMOR; CPG ISLAND; DNA METHYLATION; EOSINOPHILIA; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; INTESTINE MUCOSA; LESIONS AND DEFECTS; MALE; MIDDLE AGED; MUTATION; NUCLEOTIDE SEQUENCE; PATHOLOGY; PRECANCER;

ADENOMA; AGED; CASE-CONTROL STUDIES; COLONIC NEOPLASMS; COLONIC POLYPS; CPG ISLANDS; DILATATION, PATHOLOGIC; DNA METHYLATION; DNA MUTATIONAL ANALYSIS; EOSINOPHILIA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; MALE; MIDDLE AGED; MUCIN-6; MUTATION; PRECANCEROUS CONDITIONS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS B-RAF; RAS PROTEINS;

EID: 77649199225     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3181c6b9dd     Document Type: Article

References (41)

1. Baxter NN, Goldwasser MA, Paszat LF, et al. Association of colonoscopy and death from colorectal cancer. Ann Intern Med. 2009;150:1-8.
2. Chung SM, Chen YT, Panczykowski A, et al. Serrated polyps with "Intermediate Features" of sessile serrated polyp and microvesicular hyperplastic polyp: a practical approach to the classification of nondysplastic serrated polyps. Am J Sur Pathol. 2008;32:407-412.
3. Goel A, Nagasaka T, Arnold CN, et al. The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer. Gastroenterology. 2007;132:127-138.
4. Goldstein NS. Serrated pathway and APC (conventional)-type colorectal polyps: molecular-morphologic correlations, genetic pathways, and implications for classification. Am J Clin Pathol. 2006;125:146-153.
5. Issa JP. CpG island methylator phenotype in cancer. Nature Rev. 2004;4:988-993.
6. Jass JR. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology. 2007;50:113-130.
7. Jass JR. Molecular heterogeneity of colorectal cancer: implications for cancer control. Surg Oncol. 2007;16(suppl 1):S7-S9.
8. Jass JR, Whitehall VLJ, Young J, et al. Emerging concepts in colorectal neoplasia. Gastroenterology. 2002;123:862-876.
9. Jass JR, Baker K, Zlobec I, et al. Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a 'fusion' pathway to colorectal cancer. Histopathology. 2006;49:121-131.
10. Kakar S, Deng G, Cun L, et al. CpG island methylation is frequently present in tubulovillous and villous adenomas and correlates with size, site, and villous component. Hum Pathol. 2008;39:30-36.
11. Kambara T, Simms LA, Whitehall VLJ, et al. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut. 2004;53:1137-1144.
12. Kawasaki T, Ohnishi M, Nosho K, et al. CpG island methylator phenotype-low (CIMP-low) colorectal cancer shows not only few methylated CIMP-high-specific CpG islands, but also low-level methylation at individual loci. Mod Pathol. 2008;21:245-255.
13. Kim HC, Roh SA, Ga IH, et al. CpG island methylation as an early event during adenoma progression in carcinogenesis of sporadic colorectal cancer. J Gastroenterol Hepatol. 2005;20: 1920-1926.
14. Kuan SF, Montag AG, Hart J, et al. Differential expression of mucin genes in mammary and extramammary Paget's disease. Am J Surg Pathol. 2001;25:1469-1477.
15. Lazarus R, Junttila OE, Karttunen TJ, et al. The risk of metachro nous neoplasia in patients with serrated adenoma. Am J Clin Pathol. 2005;123:349-359.
16. Longacre TA, Fenoglio-Preiser CM. Mixed hyperplastic adenomatous polyps/serrated adenomas. A distinct form of colorectal neoplasia. Am J Surg Pathol. 1990;14:524-537.
17. Makinen MJ. Colorectal serrated adenocarcinoma. Histopathology. 2007;50:131-150.
18. Nikiforova MN, Lynch RA, Biddinger PW, et al. RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma. J Clin Endocrinol Metab. 2003;88:2318-2326.
19. Nosho K, Irahara N, Shima K, et al. Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample. PLoS ONE. 2008;3: e3698.
20. O'Brien MJ. Hyperplastic and serrated polyps of the colorectum. Gastroenterol Clin North Am. 2007;36:947-968, viii.
21. O'Brien MJ, Yang S, Clebanoff JL, et al. Hyperplastic (serrated) polyps of the colorectum: relationship of CpG island methylator phenotype and K-ras mutation to location and histologic subtype. Am J Surg Pathol. 2004;28:423-434.
22. O'Brien MJ, Yang S, Mack C, et al. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. Am J Surg Pathol. 2006;30:1491-1501.
23. Ogino S, Goel A. Molecular classification and correlates in colorectal cancer. J Mol Diagn. 2008;10:13-27.
24. Ogino S, Kawasaki T, Brahamandam M, et al. Precision and performance characterisitics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis. J Mol Diagn. 2006;8:209-217.
25. Ogino S, Kawasaki T, Kirkner GJ, et al. Evaluation of markers for CpG Island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample. J Mol Diagn. 2007;9: 305-314.
26. Ogino S, Kawasaki T, Kirkner GJ, et al. Molecular correlates with MGMT promoter methylation and silencing support CpG island methylator phenotype-low (CIMP-low) in colorectal cancer. Gut. 2007;56:1564-1571.
27. Ogino S, Nosho K, Kirkner GJ, et al. CpG island methylator pheno-type, microsatellite instability, BRAF mutation and clinical outcome in colon cancer. Gut. 2009;58:90-96.
28. Owens SR, Chiosea SI, Kuan S. Selective expression of gastric mucin MUC6 in colonic sessile serrated adenoma but not in hyperplastic polyp aids in morphological diagnosis of serrated polyps. Mod Pathol. 2008;21:660-669.
29. Pai R, Hart J, Noffsinger AE. Sessile serrated adenomas strongly predispose to sychronous serrated polyps in non-syndromic patients. Histopathology. 2010. In press.
30. Rashid A, Issa JPJ. CpG island methylation in gastroenterologic neoplasia: a maturing field. Gastroenterology. 2004;127: 1578-1588.
31. Rashid A, Shen L, Morris JS, et al. CpG island methylation in colorectal adenomas. Am J Pathol. 2001;159:1129-1135.
32. Samowitz WS, Albertsen H, Herrick J, et al. Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. Gastroenterology. 2005;129:837-845.
33. Shen L, Toyota M, Kondo Y, et al. Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer. Proc Natl Acad Sci U S A. 2007;104:18654-18659.
34. Slattery ML, Curtin K, Sweeney C, et al. Diet and lifestyle factor associations with CpG island methylator phenotype and BRAF mutations in colon cancer. Int J Cancer. 2007;120:656-663.
35. Snover DC, Jass JR, Fenoglio-Preiser C, et al. Serrated polyps of the large intestine: a morphologic and molecular review of an evolving concept. Am J Clin Pathol. 2005;124:380-391.
36. Spring KJ, Zhao ZZ, Karamatic R, et al. High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy. Gastroenterology. 2006;131: 1400-1407.
37. Torlakovic E, Skovlund E, Snover DC, et al. Morphologic reappraisal of serrated colorectal polyps. Am J Surg Pathol. 2003;27: 65-81.
38. Tuppurainen K, Makinen JM, Junttila O, et al. Morphology and microsatellite instability in sporadic serrated and non-serrated colorectal cancer. J. Pathol. 2005;207:285-294.
39. Weisenberger DJ, Siegmund KD, Campan M, et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nature Genetics. 2006;38:787-793.
40. Wong JJ, Hawkins NJ, Ward RL. Colorectal cancer: a model for epigenetic tumorigenesis. Gut. 2007;56:140-148.
41. Yang S, Farraye FA, Mack C, et al. BRAF and KRAS Mutations in hyperplastic polyps and serrated adenomas of the colorectum: relationship to histology and CpG island methylation status. Am J Surg Pathol. 2004;28:1452-1459.